Takeda Pharmaceutical (TAK) reported fiscal Q4 core earnings Thursday of 49 Japanese yen ($0.34) per share, down from 72 yen a year earlier.
Four analysts polled by FactSet expected 55.38 yen.
Revenue for the quarter ended March 31 was 1.053 trillion yen, up from 1.051 trillion yen a year earlier.
Analysts surveyed by FactSet expected 1.073 trillion yen.
The company expects core EPS for its next fiscal year to be 485 yen. Analysts surveyed by FactSet expect 508.33 yen.
The company expects full-year revenue of 4.530 trillion yen. Analysts polled by FactSet expects 4.602 trillion yen.
Takeda shares were down 3% in recent premarket activity.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。